Company Name
Xiushi Biopharma (Nantong) Co., Ltd.
Year of Establishment
2020
Company Introduction
XIUSHI Biotech is an industry-leading, innovation-driven company specializing in the development and application of bio-synthesized peptide technology. XIUSHI provides a comprehensive set of products and services for research, clinical development, and commercial manufacturing purposes to biotech and pharmaceutical companies worldwide.
Main Competitive Advantages
Experienced R&D Staff,Production Capacity,Large Product Line,Contract Manufacturing (CRO,CMO),Buyers' Specifications Accepted,Small Orders Accepted,Reputation,Quality Service,
Other Competitive Advantages
Technology: Specialized in bio-synthesized peptide
Business: Provides Drug Peptide Product and CMC Service for Drug Peptide
Team: well-known GMP experts and class-leading scientists
Facility: 3,300m2 R&D center, 6,700m2 workshop and a 20,000m2 manufacturing facility
Objective: Redefining the peptide industry through technological innovation and industrialization
Milestone
2020.10 Established company.
2022.10 The launch of innovative drug project for ultra-long acting insulin CDMO cooperation
2023.5 Received several millions USD from angel investors
2023.12 National high-tech enterprise
2024 Recieved 10+ million USD Pre-A round investment